Biography:

Peter Van Vlasselaer, PhD has over 20 years of experience in the biotech industry and is currently CEO of ARMO BioSciences. Previously, he was CEO of iPierian, ARRESTO and AVIDIA. In addition to founding ARMO, Dr. Van Vlasselaer was a co-founder of Arresto, TrueNorth and ACIR BioSciences and a member of the start-up teams of InterMune (ITMN) and Dendreon (DNDN). He currently serves on the boards of ARMO, TrueNorth, and Blade Therapeutics.

Dr. Van Vlasselaer has a degree in Zoology and a PhD in Immunology from the Catholic University of Leuven, Belgium. He has authored several peer reviewed scientific publications and book chapters and is an inventor on multiple patents.